George Haig, PharmD
TrueBinding, Inc. · AbbVie
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name George Haig, PharmD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:10 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04920786 · Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy SubjectsTrueBinding, Inc. · completed · Alzheimer Disease · study director
- Ph2NCT01834638 · Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)AbbVie · terminated · Schizophrenia · study director
- Ph2NCT01678755 · A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in SchizophreniaAbbVie (prior sponsor, Abbott) · completed · Schizophrenia · study director
- Ph2NCT01655680 · A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in SchizophreniaAbbVie (prior sponsor, Abbott) · completed · Schizophrenia · study director
- Ph2NCT01095562 · Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With SchizophreniaAbbVie (prior sponsor, Abbott) · completed · Cognitive Deficits in Schizophrenia · study director
- Ph2NCT01077700 · Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With SchizophreniaAbbVie (prior sponsor, Abbott) · completed · Cognitive Deficits in Schizophrenia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.